Sistema Biotech has developed PreMama DNA test, which analyzes 48 genes in a woman’s DNA responsible for hormonal disorders and implantation disorders, pregnancy complications and predisposition to thrombophilia, as well as other possible causes.
The development is being introduced into the medical practice at Medsi, a private chain of clinics (Medsi and Sistema Biotech are part of Sistema AFK).
“These are the most common types of female reproductive system disorders. The study also provides an individual selection of metabolic correctors that can compensate for the genetically determined imbalance of trace elements in the body, and can contribute to the normalization of reproductive function,” Medsi’s press service noted.
Natalia Pozdnyakova, Director of Science at Sistema Biotech, comments:
“As a rule, couples desperate to have a baby resort to assisted reproductive technologies, namely, IVF. But few people know that this treatment should be preceded by an intermediate stage, which helps restore reproductive function for patients at any age and any infertility status. This is the restoration of biochemical processes in the body of a man or a woman, which is associated with their individual genotype and environmental factors, such as exposure to sunlight, the level of toxins in the body, and the specifics of metabolic processes. Such a correction is indicated not only in cases of idiopathic infertility, but also for those with previously unsuccessful IVF attempts. The treatment does not exclude the option of the use of ART later. Our PreMama genetic test is developed taking into account international experience, the successful use of DNA analysis by foreign reproductologists, gynecologists, urologists, and andrologists. This analysis is able to detect non-obvious causes for a couple being unable to conceive, as well as predict and prevent possible difficulties with pregnancy for a couple. According to these data, the doctor will be able to correctly adjust the treatment strategy for a patient with infertility and mitigate their risks by the time pregnancy planning begins.”
According to the World Health Organization (WHO), about 50 million married couples around the world cannot have a child due to female or male infertility. In half of the cases, the issue is caused by genetic disorders.
